APA (7th ed.) Citation

H, L., YC, O., HC, F., CC, T., YW, W., YY, C., . . . CH, W. (2025). Prognostic nomogram for advanced epithelial ovarian cancer in the era of homologous recombination testing and PARP inhibitor therapy. American journal of cancer research, 15(5), 2439. https://doi.org/10.62347/XYTZ1766

Chicago Style (17th ed.) Citation

H, Lin, Ou YC, Fu HC, Tsai CC, Wang YW, Chen YY, Huang SW, and Wu CH. "Prognostic Nomogram for Advanced Epithelial Ovarian Cancer in the Era of Homologous Recombination Testing and PARP Inhibitor Therapy." American Journal of Cancer Research 15, no. 5 (2025): 2439. https://doi.org/10.62347/XYTZ1766.

MLA (9th ed.) Citation

H, Lin, et al. "Prognostic Nomogram for Advanced Epithelial Ovarian Cancer in the Era of Homologous Recombination Testing and PARP Inhibitor Therapy." American Journal of Cancer Research, vol. 15, no. 5, 2025, p. 2439, https://doi.org/10.62347/XYTZ1766.